Design of Recombinant Hemoglobins for Use in Transfusion Fluids

Critical Care Clinics

Volumn 25, Issue 2, 2009, Pages 357-371

  Fronticelli, Clara ^a   Koehler, Raymond C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood substitute; Hemoglobin; Myoglobin; Nitric oxide; Oxygen carrier; Transfusion

Indexed keywords

ARTIFICIAL BLOOD; BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; HEME; HEMOGLOBIN; HEMOSPAN; MUTANT PROTEIN; MYOGLOBIN; OXYVITA; PLASMA SUBSTITUTE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; SANGUINATE; UNCLASSIFIED DRUG;

DRUG DESIGN; DRUG SYNTHESIS; MOLECULAR WEIGHT; OXYGEN AFFINITY; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW; SURFACE PROPERTY;

ANIMALS; BLOOD SUBSTITUTES; BLOOD TRANSFUSION; HEME; HEMOGLOBINS; HUMANS; MUTAGENESIS, SITE-DIRECTED; MYOGLOBIN; NITRIC OXIDE; OXIDATION-REDUCTION; OXYGEN; RECOMBINANT PROTEINS;

EID: 63049083139     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2008.12.010     Document Type: Review

References (71)

1. Baron J.F. Blood substitutes. Haemoglobin therapeutics in clinical practice. Crit Care 3 (1999) R99-102
2. Chang T.M. Red blood cell substitutes. Baillieres Best Pract Res Clin Haematol 13 (2000) 651-667
3. Stowell C.P., Levin J., Spiess B.D., et al. Progress in the development of RBC substitutes. Transfusion 41 (2001) 287-299
4. Alayash A.I. Oxygen therapeutics: can we tame haemoglobin?. Nat Rev Drug Discov 3 (2004) 152-159
5. Stowell C. Blood substitutes: time for a deep breath. Transfusion 48 (2008) 574-575
6. Urbaitis B., Razynska A., Corteza Q., et al. Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins. J Lab Clin Med 117 (1991) 115-121
7. Matheson B., Razynska A., Kwansa H., et al. Appearance of dissociable and cross-linked hemoglobins in the renal hilar lymph. J Lab Clin Med 135 (2000) 459-464
8. Sampei K., Ulatowski J.A., Asano Y., et al. Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am J Physiol Heart Circ Physiol 289 (2005) H1191-H1201
9. Page T.C., Light W.R., McKay C.B., et al. Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance. Microvasc Res 55 (1998) 54-64
10. McCarthy M.R., Vandegriff K.D., and Winslow R.M. The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem 92 (2001) 103-117
11. 2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol 33 (2005) 1-12
12. Tsai A.G., Cabrales P., Manjula B.N., et al. Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers. Blood 108 (2006) 3603-3610
13. 2 therapeutics. Am J Physiol Heart Circ Physiol 285 (2003) H1411-H1419
14. Wettstein R., Tsai A.G., Erni D., et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 31 (2003) 1824-1830
15. Winslow R.M. αα-crosslinked hemoglobin: was failure predicted by preclinical testing?. Vox Sang 79 (2000) 1-20
16. Hughes G.S., Antal E.J., Locker P.K., et al. Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans. Crit Care Clin 24 (1996) 756-764
17. Kasper S.M., Walter M., Grune F., et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 83 (1996) 921-927
18. Gould S.A., Moore E.E., Hoyt D.B., et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 187 (1998) 113-120
19. Gould S.A., Moore E.E., Hoyt D.B., et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 195 (2002) 445-452
20. Matheson B., Kwansa H.E., Bucci E., et al. Vascular response to infusions of a nonextravasating hemoglobin polymer. J Appl Phys 93 (2002) 1479-1486
21. Nho K., Glower D., Bredehoeft S., et al. PEG-bovine hemoglobin: safety in a canine dehydrated hypovolemic-hemorrhagic shock model. Biomater Artif Cells Immobilization Biotechnol 20 (1992) 511-524
22. Olofsson C., Ahl T., Johansson T., et al. A multicenter clinical study of the safety and activity of maleimide-polyethylene glycol-modified hemoglobin (Hemospan) in patients undergoing major orthopedic surgery. Anesthesiology 105 (2006) 1153-1163
23. Olofsson C., Nygards E.B., Ponzer S., et al. A randomized, single-blind, increasing dose safety trial of an oxygen-carrying plasma expander (Hemospan) administered to orthopaedic surgery patients with spinal anaesthesia. Transfus Med 18 (2008) 28-39
24. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299 (2008) 2304-2312
25. Nagai K., and Thogersen H.C. Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli. Nature 309 (1984) 810-812
26. Fronticelli C., O'Donnell J.K., and Brinigar W.S. Recombinant human hemoglobin: expression and refolding of beta-globin from Escherichia coli. J Protein Chem 10 (1991) 495-501
27. Tame J., Shih D.T., Pagnier J., et al. Functional role of the distal valine (E11) residue of alpha subunits in human haemoglobin. J Mol Biol 218 (1991) 761-767
28. Sanna M.T., Razynska A., Karavitis M., et al. Assembly of human hemoglobin. Studies with Escherichia coli-expressed alpha-globin. J Biol Chem 272 (1997) 3478-3486
29. Looker D., Abbott-Brown D., Cozart P., et al. A human recombinant haemoglobin designed for use as a blood substitute. Nature 356 (1992) 258-260
30. Looker D., Mathews A.J., Neway J.O., et al. Expression of recombinant human hemoglobin in Escherichia coli. Meth Enzymol 231 (1994) 364-374
31. Shen T.J., Ho N.T., Simplaceanu V., et al. Production of unmodified human adult hemoglobin in Escherichia coli. Proc Natl Acad Sci USA 90 (1993) 8108-8112
32. Scott E.E., Paster E.V., and Olson J.S. The stabilities of mammalian apomyoglobins vary over a 600-fold range and can be enhanced by comparative mutagenesis. J Biol Chem 275 (2000) 27129-27136
33. Kihm A.J., Kong Y., Hong W., et al. An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 417 (2002) 758-763
34. Gell D., Kong Y., Eaton S.A., et al. Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein. J Biol Chem 277 (2002) 40602-40609
35. Feng L., Gell D.A., Zhou S., et al. Molecular mechanism of AHSP-mediated stabilization of alpha-hemoglobin. Cell 119 (2004) 629-640
36. 2 transporter. Am J Physiol Heart Circ Physiol 285 (2003) H549-H561
37. Olson J.S. Genetic engineering of myoglobin as a simple prototype for hemoglobin-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol 22 (1994) 429-441
38. Springer B.A., Sligar S.G., Olson J.S., et al. Mechanisms of ligand recognition by myoglobin. Chem Rev 94 (1994) 699-714
39. Piro M.C., Militello V., Leone M., et al. Heme pocket disorder in myoglobin: reversal by acid-induced soft refolding. Biochemistry 40 (2001) 11841-11850
40. Fronticelli C., Bellelli A., and Brinigar W.S. Approaches to the engineering of hemoglobin-based oxygen carriers. Transfus Altern Transfus Med 5 (2004) 516-522
41. Fronticelli C., Brinigar W.S., Olson J.S., et al. Recombinant human hemoglobin: modification of the polarity of the beta-heme pocket by a valine67(E11)→threonine mutation. Biochemistry 32 (1993) 1235-1242
42. Pechik I., Ji X., Fidelis K., et al. Crystallographic, molecular modeling, and biophysical characterization of the valine beta 67 (E11)→threonine variant of hemoglobin. Biochemistry 35 (1996) 1935-1945
43. Olson J.S., Foley E.W., Rogge C., et al. NO scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 36 (2004) 685-697
44. Ulatowski J.A., Nishikawa T., Matheson-Urbaitis B., et al. Regional blood flow alterations after bovine fumaryl ββ-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med 24 (1996) 558-565
45. Olson J.S., and Maillett D.S. Designing recombinant hemoglobin for use as a blood substitute. In: Winslow R.M. (Ed). Blood substitutes (2006), Academic Press/Elsevier, Amsterdam 354-374
46. Doherty D.H., Doyle M.P., Curry S.R., et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol 16 (1998) 672-676
47. Rohlfs R.J., Bruner E., Chiu A., et al. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 273 (1998) 12128-12134
48. Qin X., Kwansa H., Bucci E., et al. Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin. J Appl Phys 100 (2006) 336-342
49. Koehler R.C., Fronticelli C., and Bucci E. Insensitivity of cerebral oxygen transport to oxygen affinity of hemoglobin-based oxygen carriers. Biochim Biophys Acta 1784 (2008) 1387-1394
50. Resta T.C., Walker B.R., Eichinger M.R., et al. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Phys 93 (2002) 1327-1336
51. Raat N.J., Liu J.F., Doyle M.P., et al. Effects of recombinant-hemoglobin solutions rHb2.0 and rHb1.1 on blood pressure, intestinal blood flow, and gut oxygenation in a rat model of hemorrhagic shock. J Lab Clin Med 145 (2005) 21-32
52. Fronticelli C., Sanna M.T., Perez-Alvarado G.C., et al. Allosteric modulation by tertiary structure in mammalian hemoglobins. Introduction of the functional characteristics of bovine hemoglobin into human hemoglobin by five amino acid substitutions. J Biol Chem 270 (1995) 30588-30592
53. Fronticelli C., Bobofchak K.M., Karavitis M., et al. Introduction of a new regulatory mechanism into human hemoglobin. Biophys Chem 98 (2002) 115-126
54. Tsai C.H., and Ho C. Recombinant hemoglobins with low oxygen affinity and high cooperativity. Biophys Chem 98 (2002) 15-25
55. Pearce L., and Gawryl M. Overview of preclinical and clinical efficacy of Biopure's HBOCs. In: Chang T. (Ed). Blood substitutes: principles, methods, products and clinical trials (1998), Karger/Landes, Basel (Switzerland)
56. Svergun D.I., Ekstrom F., Vandegriff K.D., et al. Solution structure of poly (ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic. Biophys J 94 (2008) 173-181
57. Fronticelli C., Arosio D., Bobofchak K.M., et al. Molecular engineering of a polymer of tetrameric hemoglobins. Proteins 44 (2001) 212-222
58. 2-affinity recombinant hemoglobin polymers in mouse. J Appl Phys 100 (2006) 1688-1691
59. Hughes G.S., Francom S.F., Antal E.J., et al. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 126 (1995) 444-451
60. Carmichael F.J., Ali A.C., Campbell J.A., et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 28 (2000) 2283-2292
61. Fablet C., Marden M.C., Green B.N., et al. Stable octameric structure of recombinant hemoglobin alpha(2)beta(2)83 Gly→Cys. Protein Sci 12 (2003) 690-695
62. Baldwin A.L. Modified hemoglobins produce venular interendothelial gaps and albumin leakage in the rat mesentery. Am J Phys 277 (1999) H650-H659
63. Dull R.O., DeWitt B.J., Dinavahi R., et al. Quantitative assessment of hemoglobin-induced endothelial barrier dysfunction. J Appl Phys 97 (2004) 1930-1937
64. 2 carriers on intestinal integrity and microvascular leakage. Am J Physiol Heart Circ Physiol 283 (2002) H1292-H1301
65. Baldwin A.L., Wilson L.M., and Valeski J.E. Ultrastructural effects of intravascularly injected polyethylene glycol-hemoglobin in intestinal mucosa. Am J Physiol Heart Circ Physiol 275 (1998) H615-H625
66. Burke T.K., Teng X., Patel R.P., et al. Effects of S-nitrosation on hemoglobin-induced microvascular damage. Antioxid Redox Signal 8 (2006) 1093-1101
67. Mito T., Nemoto M., Kwansa H., et al. Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse. Stroke 40 (2009) 278-284
68. Bucci E., Razynska A., Kwansa H., et al. Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid. J Lab Clin Med 128 (1996) 146-153
69. Watson J.C., Doppenberg E.M.R., Bullock M.R., et al. Effects of the allosteric modification of hemoglobin on brain oxygen and infarct size in a feline model of stroke. Stroke 28 (1997) 1624-1630
70. Springer B.A., and Sligar S.G. High-level expression of sperm whale myoglobin in E coli. Proc Natl Acad Sci USA 84 (1987) 8961-8965
71. Manjula B.N., Tsai A.G., Intaglietta M., et al. Conjugation of multiple copies of polyethylene glycol to hemoglobin facilitated through thiolation: influence on hemoglobin structure and function. Protein J 24 (2005) 133-146